Integral Ad Science (NASDAQ:IAS) Price Target Lowered to $16.00 at Piper Sandler

Integral Ad Science (NASDAQ:IAS) had its price target trimmed by Piper Sandler from $18.00 to $16.00 in a research note published on Wednesday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock.

Other analysts have also issued research reports about the stock. Raymond James lifted their price objective on shares of Integral Ad Science from $13.00 to $15.00 and gave the company an “outperform” rating in a research note on Friday, August 2nd. Truist Financial decreased their price target on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a research note on Wednesday. Barclays increased their price objective on shares of Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a research report on Monday, August 5th. Morgan Stanley boosted their target price on Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 23rd. Finally, Craig Hallum cut their price target on Integral Ad Science from $18.00 to $16.00 and set a “buy” rating on the stock in a report on Wednesday. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $15.70.

Integral Ad Science Price Performance

Shares of NASDAQ IAS opened at $10.79 on Wednesday. The company has a quick ratio of 3.76, a current ratio of 3.76 and a debt-to-equity ratio of 0.10. The company has a market capitalization of $1.74 billion, a PE ratio of 55.00, a P/E/G ratio of 1.90 and a beta of 1.52. The firm has a fifty day simple moving average of $11.13 and a 200 day simple moving average of $10.46. Integral Ad Science has a twelve month low of $7.98 and a twelve month high of $17.53.

Integral Ad Science (NASDAQ:IAS) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. Integral Ad Science had a return on equity of 3.52% and a net margin of 6.39%. The company had revenue of $133.50 million for the quarter, compared to the consensus estimate of $138.06 million. During the same period in the previous year, the business earned ($0.09) EPS. The firm’s revenue was up 11.0% compared to the same quarter last year. On average, sell-side analysts forecast that Integral Ad Science will post 0.23 EPS for the current year.

Insiders Place Their Bets

In related news, CFO Tania Secor sold 5,240 shares of the stock in a transaction on Monday, October 7th. The stock was sold at an average price of $10.11, for a total value of $52,976.40. Following the completion of the sale, the chief financial officer now directly owns 248,223 shares of the company’s stock, valued at approximately $2,509,534.53. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Integral Ad Science news, CFO Tania Secor sold 5,240 shares of Integral Ad Science stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total transaction of $52,976.40. Following the transaction, the chief financial officer now owns 248,223 shares of the company’s stock, valued at $2,509,534.53. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Lisa Utzschneider sold 10,481 shares of the company’s stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total value of $105,962.91. Following the completion of the transaction, the chief executive officer now directly owns 239,709 shares of the company’s stock, valued at approximately $2,423,457.99. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 23,006 shares of company stock valued at $240,296. Corporate insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. nVerses Capital LLC purchased a new position in shares of Integral Ad Science during the 3rd quarter valued at $45,000. Ameritas Investment Partners Inc. raised its stake in Integral Ad Science by 40.1% in the 1st quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock valued at $67,000 after acquiring an additional 1,924 shares during the period. Quantbot Technologies LP bought a new stake in Integral Ad Science in the 3rd quarter valued at about $106,000. XTX Topco Ltd purchased a new stake in Integral Ad Science during the second quarter valued at about $113,000. Finally, ProShare Advisors LLC bought a new position in Integral Ad Science during the first quarter worth about $121,000. 95.78% of the stock is currently owned by hedge funds and other institutional investors.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.